Yunfei Shi

Integration of comprehensive genomic profiling, tumor mutational burden, and PD‐L1 expression to identify novel biomarkers of immunotherapy in non‐small cell lung cancer

Yunfei Shi, Youming Lei, Li Liu et al. · Cancer Medicine · 2021 · 115 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Hepatitis B virus-associated diffuse large B-cell lymphoma: unique clinical features, poor outcome, and hepatitis B surface antigen-driven origin

Lijuan Deng, Yuqin Song, Ken H. Young et al. · Oncotarget · 2015 · 97 citations · Full text

Medicine, Oncology, Pathology +15

The Bruton's tyrosine kinase inhibitor ibrutinib exerts immunomodulatory effects through regulation of tumor-infiltrating macrophages

Lingyan Ping, Ning Ding, Yunfei Shi et al. · Oncotarget · 2017 · 86 citations · Full text

Medicine, Oncology, Pharmacology +17

Detecting Fibroblast Activation Proteins in Lymphoma Using ⁶⁸Ga-FAPI PET/CT

Xiao Jin, Maomao Wei, Guochang Wang et al. · Journal of Nuclear Medicine · 2021 · 72 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Correlation of mutational landscape and survival outcome of peripheral T-cell lymphomas

Yingying Ye, Ning Ding, Lan Mi et al. · Experimental Hematology and Oncology · 2021 · 65 citations · Full text

Medicine, Genetics, Oncology +17